With the cancer drug market recently having hit US$100 billion, and some industry experts concerned that cancer drug prices are unsustainable, two groups have started working towards calculating the ...

In the midst of physician concerns that Part B drug reimbursements are too low, the Department of Health and Human Services' Office of Inspector General (OIG) is suggesting the Centers for Medicare ...

As governments grapple with the rising cost of the opioid crisis, one group may have found a way to predict how high those costs will go. For every three fatal overdoses, a local government's public ...

It costs around US$880 million to bring a new drug to market, even when the price of failure and the cost of capital are included, suggests the latest stab at calculating the cost of drug development.